 |
市场调查报告书
商品编码
1378638
桿状病毒表达系统市场：按产品类型、按应用、按最终用户、按地区Baculovirus Expression System Market, By Product Type, By Application, By End User, By Geography |
||||||
价格
简介目录
桿状病毒表现系统市场规模预计将从 2023 年的 3.6849 亿美元增加到 2030 年的 6.6075 亿美元，预测期内年复合成长率为 8.7%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 3.685 亿美元 |
| 实绩资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期年复合成长率 | 8.70% | 2030年市场规模预测 | 6.607 亿美元 |
图 1. 桿状病毒表现系统的全球市场占有率(%)（按地区），2023 年
桿状病毒表现系统是生物技术中用于生产重组蛋白的通用且广泛使用的工具。桿状病毒是感染昆虫细胞的昆虫病毒，经过改造后可表达感兴趣的外源基因。与其他表现系统系统相比，此表现系统具有多种优势，包括高蛋白产量、转译后修饰和可扩展性。
桿状病毒表现系统应用于多个领域，包括生物製药生产、蛋白质研究、疫苗开发和基因治疗。该系统多年来经过广泛研究和优化，并提高了效率和多功能性。
市场动态：
桿状病毒表达系统市场预计在未来几年将显着成长。这种增长是由多种因素推动的，包括用于治疗和研究目的的重组蛋白的需求不断增加。桿状病毒表达系统由于能够产生大量复杂的功能性蛋白质而在生物製药行业中受到青睐。
市场的另一个驱动因素是对开发新型治疗方法和疫苗的研发活动的投资不断增加。桿状病毒表现系统为此类生技药品的生产提供了可靠且具成本效益的平台。
但市场也存在一定的抑制因素。主要挑战之一是使用桿状病毒表达系统的蛋白质生产过程复杂且耗时。优化和扩展系统需要技术专业知识并且非常耗时。
也就是说，市场上存在大量成长机会。对个人化医疗和先进疗法开发的日益关注正在创造对客製化蛋白质生产系统的需求。桿状病毒表现系统以其弹性和产生多种蛋白质的能力，能够很好地满足这项需求。
本研究的主要特点
- 本报告对全球桿状病毒表现系统市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率。
- 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 介绍了全球桿状病毒表达系统市场的主要参与者，包括公司亮点、产品系列、主要亮点、财务实绩和策略。
- 该报告的见解使行销人员和经营团队负责人就未来的产品发布、技术升级、市场扩张和行销策略做出明智的资讯。
- 全球桿状病毒表达系统市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以从用于分析全球桿状病毒表达系统市场的策略矩阵中受益，这有助于决策。
目录
第1章调查目的和假设
- 研究目标
- 假设
- 简称
第2章市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第3章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 用于治疗和研究目的的重组蛋白需求不断增加
- 抑制因素
- 复杂且耗时的蛋白质生产过程
- 机会
- 对个人化医疗和先进治疗方法开发的日益关注
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 併购场景
第4章桿状病毒表现系统市场－冠状病毒（COVID-19）大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第5章桿状病毒表现系统市场，依产品类型，2023-2030
- 桿状病毒
- 表达载体
- 试剂
- 其他的
第6章桿状病毒表现系统市场，依应用划分，2023-2030 年
- 疗法
- 疫苗
- 蛋白质精製
- 其他的
第7章桿状病毒表达系统市场，按最终用户划分，2023-2030 年
- 生物製药公司
- 调查机构
- 其他的
第8章桿状病毒表现系统市场，按地区，2023-2030
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东和非洲
第9章竞争形势
- Thermo Fisher Scientific
- Merck KGaA
- Takara Bio（Part of Otsuka Holdings）
- Agilent Technologies
- Oxford Expression Technologies
- Promega Corporation
- Qiagen NV
- Bio-Rad Laboratories
- New England Biolabs
- Genscript Biotech Corporation
- Syngene International Limited
- Sartorius AG（BIA Separations）
- Aragen Bioscience
- Vivopure
- Creative Biogene
- Absolute Antibody
- Rockland Immunochemicals
- Protein Technologies, Inc.（PTI）
- Proteogenix
- Virovek
第10章章
- 调查方法
- 关于出版商
简介目录
Product Code: CMI6360
The Baculovirus Expression System Market size is expected to reach US$ 660.75 million by 2030, from US$ 368.49 million in 2023, at a CAGR of 8.7% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 368.5 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 8.70% | 2030 Value Projection: | US$ 660.7 Mn |
Figure 1. Global Baculovirus Expression System Market Share (%), by Region, 2023
The Baculovirus Expression System is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculoviruses are insect viruses that infect insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems, including high protein yields, post-translational modifications, and scalability.
The baculovirus expression system has found applications in various fields, such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.
Market Dynamics:
The Baculovirus Expression System market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.
Another driver of the market is the rising investment in research and development activities for the development of novel therapies and vaccines. The Baculovirus Expression System provides a reliable and cost-effective platform for the production of these biologics.
However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the Baculovirus Expression System. The optimization and scaling-up of the system require technical expertise and can be labor-intensive.
Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics create a demand for customized protein production systems. The Baculovirus Expression System, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.
Key Features of the Study:
- This report provides in-depth analysis of the global Baculovirus Expression System market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), with 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- Key players in the global Baculovirus Expression System market are profiled, including company highlights, product portfolios, key highlights, financial performance, and strategies.
- The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek.
- Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
- The global Baculovirus Expression System market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would benefit from the strategy matrices used in analyzing the global Baculovirus Expression System market, making decision-making easier.
Baculovirus Expression System Market Segmentation:
- By Product Type
- Baculovirus
- Expression Vector
- Reagents
- Others
- By Application
- Therapeutics
- Vaccines
- Protein Purification
- Others
- By End User
- Biopharmaceutical Companies
- Research Institutes
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- Top companies in Baculovirus Expression System Market:
- Thermo Fisher Scientific
- Merck KGaA
- Takara Bio (Part of Otsuka Holdings)
- Agilent Technologies
- Oxford Expression Technologies
- Promega Corporation
- Qiagen N.V.
- Bio-Rad Laboratories
- New England Biolabs
- Genscript Biotech Corporation
- Syngene International Limited
- Sartorius AG (BIA Separations)
- Aragen Bioscience
- Vivopure
- Creative Biogene
- Absolute Antibody
- Rockland Immunochemicals
- Protein Technologies, Inc. (PTI)
- Proteogenix
- Virovek
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- The increasing demand for recombinant proteins for therapeutic and research purposes
- Restraints
- The complex and time-consuming process of protein production
- Opportunities
- The increasing focus on personalized medicine and the development of advanced therapeutics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Baculovirus Expression System Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Baculovirus Expression System Market , By Product Type, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Baculovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Expression Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Baculovirus Expression System Market , By Application, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
- Protein Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
7. Baculovirus Expression System Market , By End User, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
8. Baculovirus Expression System Market , By Region, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
9. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio (Part of Otsuka Holdings)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oxford Expression Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genscript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Syngene International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG (BIA Separations)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aragen Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vivopure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Absolute Antibody
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Rockland Immunochemicals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Protein Technologies, Inc. (PTI)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Proteogenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Virovek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
2024-2032 年按产品、应用、最终用户（学术研究机构、生物技术和製药公司、合约研究组织）和地区分類的蛋白质表现市场报告
2024-2032 年按产品、方法、应用、最终用户和地区分類的无细胞蛋白表达市场报告
蛋白质表现市场 - 全球和区域分析：按应用、按最终用户、按产品、按表达系统、按地区 - 分析和预测 (2023-2033)
桿状病毒表达系统市场，按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
蛋白质表达市场规模,份额和趋势分析报告：按表达系统（原核生物,哺乳动物细胞）,副产品（试剂,感受态细胞）,按应用（治疗,工业）,最终用途细分趋势2023-2030
无细胞蛋白表达市场：副产品、表达模式、用途和最终用户 - 2023-2030 年全球预测
蛋白质表现市场：按类型、产品和服务、用途、最终用户划分 - 全球预测 2023-2030
全球无细胞蛋白表达市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测
蛋白质表达市场：全球行业趋势、份额、规模、增长机会、2023-2028 年预测
全球蛋白质表达市场：市场规模、份额、趋势分析、机会、预测——按系统类型、应用、最终用户、地区划分 (2019-2029)
▼